Jeffrey Dayno

Dr. Dayno is currently the Chief Medical Officer of Egalet. He spent ten years in clinical and academic medicine before moving into the pharmaceutical industry. He previously served as Vice President, Global Medical Affairs at ViroPharma, Chief Medical Officer at Labopharm, Inc., and Vice President of Medical Affairs at Cephalon, Inc. Dr. Dayno started his career in the pharmaceutical industry in 1998 at Merck & Co., Inc., where he spent seven years in positions of increasing responsibility in the medical and scientific affairs divisions.

Before moving into leadership roles in the pharmaceutical and biotechnology industry, Dr. Dayno held a number of clinical appointments, including Assistant Professor of Neurology, Jefferson Medical College, and Medical Director of the Jefferson Health System Stroke Center Network. Dr. Dayno is currently a member of the Board of Visitors of Temple University School of Medicine and is a former Chairman of the Philadelphia Stroke Council.

Dr. Dayno earned his medical degree from Temple University School of Medicine, completed a fellowship in stroke and cerebrovascular disorders in the Department of Neurology at Henry Ford Hospital, a National Institutes of Health (NIH) Clinical Research Center for stroke and headache, and was board certified in neurology.